mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.4 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.4 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |